Inhibikase Therapeutics shares owned by Vanguard Capital Management
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Vanguard Capital Management
from 13F filings
Historical chart of Vanguard Capital Management investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Vanguard Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Vanguard Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $7.5M | 4.5M | 1.68 |
More positions owned by Vanguard Capital Management
View all positions for Vanguard Capital Management